Nanoligent closes a €12 million series A round led by Inveready, joined by CDTI, Clave Capital, i&i Biotech Fund, Italian Angels for Growth, and Avanteca

Biotech Health services Manufacturing Software Services

Investments

06 September 2025

Nanoligent (company)

Biotech Health services Manufacturing Software Services

Total investments received (USD): 16.99m

Round value (USD): 14.08m

Round investors: CDTI Clave Mayor Inveready Italian Angels for Growth AVANTECA Partners i&i Biotech Fund

Industry: Biotech Health services Manufacturing Software Services

Health services Software Services

Investments 10 January 2026

Biotech Health services Manufacturing

News 06 September 2025

Biotech Health services Manufacturing

Investments 01 September 2025

Biotech Hardware Health services Manufacturing

Investments 03 July 2025

Electronics Hardware Manufacturing Software Services

Investments 09 June 2025